Tag: halfbillion
Innate pharma: The half-billion revenue mark is approaching for Innate Pharma’s flagship molecule
(BFM Bourse) – The “monalizumab” molecule developed by French biotech and acquired by AstraZeneca aims to simultaneously boost the activity of two types of immune cells against cancer. The start…